Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Vitamin A derivative, acetate ester of retinol....
Fluoroquinolone; topoisomerase IV and bacterial...
Endogenous peptide hormone, involved in growth ...
Glucosinolate found in cruciferous vegetables.<...
α7 nAChR partial agonist, 5-HT3 antagonist.
Potential AhR binding agent.
Non-opioid analgesic.
FIASMA, μOR agonist, potential HCN channel blo...
Aromatase inhibitor.
Statin; HMG-CoA reductase inhibitor.
Steroid; AR antagonist.
Everolimus impurity
Isoquinoline alkaloid found in a variety of pla...
Fermentation impurity
Calpain I/II inhibitor.
Fluoroquinolone, S-(-) isomer of ofloxacin; top...
Fluorinated aminopropyl carbazole, neuroprotect...
BUB1 inhibitor.
Triterpenoid
CDK4/6 inhibitor.